Send to

Choose Destination
Diabetes Educ. 2005 Nov-Dec;31(6):849-57.

Use of continuous subcutaneous insulin infusion (insulin pump) therapy in the hospital setting: proposed guidelines and outcome measures.

Author information

The Division of Endocrinology, Mayo Clinic, Scottsdale, Arizona (Dr Cook, Ms Boyle, Dr Roust)
Division of Endocrinology, Diabetes, Nutrition, and Metabolism and Department of Health Care Policy and Research, Mayo Clinic, Rochester
The Department of Nursing, Mayo Clinic, Scottsdale, Arizona (Ms Cisar, Ms Miller-Cage)
The Department of Neurologic Surgery, Mayo Clinic, Scottsdale, Arizona (Dr Zimmerman)

Erratum in

  • Diabetes Educ. 2006 Jan-Feb;32(1):130.



Individuals whose diabetes is being treated in the outpatient setting via an insulin pump often wish to maintain this therapy during hospitalization. The authors propose guidelines for management of patients on insulin pumps who require a hospital admission.


A collaborative interinstitutional task force reviewed current available information regarding the use of insulin pumps in the hospital.


There was little information in the medical literature on how to manage individuals on established insulin pump therapy during a hospital stay. The task force believed that a policy that promotes patient independence through continuation of insulin pump therapy while ensuring patient safety was possible. A set of contraindications for continued use of pump therapy in the hospital are proposed. A sample patient consent form and order set are presented. Finally, measures that can be used to assess effectiveness of an inpatient insulin pump policy are outlined.


Patients on established insulin pump therapy do not necessarily have to discontinue treatment while hospitalized. However, clear policies and procedures should be established at the institutional level to guide continued use of the technology in the acute care setting.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center